Drugs.com - FDA MedWatch Alerts

Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions

Audience: Patient, Health Professional, Pharmacy, Immunology March 10, 2025 -- As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the...

Mar 11, 2025 - 20:15
 0
Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions
Audience: Patient, Health Professional, Pharmacy, Immunology March 10, 2025 -- As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the...
Read More

Tags:

Previous Article

Genetic, developmental, and neural changes underlying the evolution of butterfly...

Next Article

Kohl’s beats Street with Q4 losses but predicts more declines in FY25

Related Posts

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns

FDA is Alerting Patients and Health Care Professionals ...

Feb 9, 2025  0

Veata LLC Issues Voluntary Nationwide Recall of Endurance Pro Capsules Due to the Potential Presence of Undeclared Sildenafil

Veata LLC Issues Voluntary Nationwide Recall of Enduran...

Feb 9, 2025  0

FDA Warns Against Purchasing or Using Chemical Peel Skin Products Without Professional Supervision

FDA Warns Against Purchasing or Using Chemical Peel Ski...

Feb 9, 2025  0